DKSH has entered a partnership with Parhelia Bioscience, pioneers of spatial biology automation to be their exclusive distributor in Australia and New Zealand.
Melbourne, Australia, November 28, 2025 – DKSH, a leading provider of Market Expansion Services, has announced a new exclusive distribution agreement with Parhelia Biosciences Corporation, a US-based innovator in sample preparation automation for spatial biology applications. This partnership marks Parhelia’s entry into Australia and New Zealand, with DKSH providing comprehensive sales, services, and customer support.
Headquartered in Ashland Oregon, Parhelia Biosciences is known for its cutting-edge instrumentation platforms that automate tissue staining preparation for spatial biology workflows improving efficiency and ensuring uniformity. These technologies are critical in advancing research in cancer, immunology, neuroscience, developmental biology, and infectious diseases.
Under the agreement, DKSH will serve as the exclusive distributor of Parhelia’s solutions in ANZ, targeting medical research customers in academia and industry. The partnership will leverage DKSH’s strong local presence, experienced Life Science Instrumentation team, and proven track record in scientific distribution to accelerate Parhelia’s growth in the region. Parhelia selected DKSH for its local expertise, market reach, and robust service infrastructure, ensuring that customers receive not only high-quality products but also dedicated support throughout the research lifecycle.
“DKSH’s deep understanding of the ANZ market and commitment to customer success made them the ideal partner for our expansion,” said Nikolay Samusik, CEO, Parhelia Biosciences. “We look forward to working together to empower researchers with streamlined automated workflows.
“We are proud to partner with Parhelia Biosciences and bring their innovative automation solutions to our customers in Australia and New Zealand,” said Dr Richard Speight, General Manager, Technology, DKSH Australia and New Zealand. “This collaboration enhances our spatial biology offering and supports our mission to empower researchers with the tools they need to accelerate discovery.”
This partnership underscores DKSH’s commitment to expanding its footprint in the life sciences sector and delivering value to both partners and customers through tailored market expansion strategies.
About Parhelia Biosiences
Parhelia Biosciences, founded by industry pioneers, is transforming spatial biology research. The company offers a versatile, open platform for automated sample preparation for spatial assays, including instruments, reagent kits, and software. They aim to make cutting-edge spatial technologies widely available, robust, inter-operable, and easy to use. www.parheliabio.com
About DKSH
For 160 years, DKSH has been delivering growth for companies in Asia and beyond its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 28,060 specialists, generating net sales of CHF 11.1 billion in 2024. DKSH Business Unit Technology offers complete solutions for specialized scientific and industrial applications. With around 1,820 specialists, the Business Unit generated net sales of CHF 549 million in 2024. www.dksh.com/tec